# Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia

> **NCT01052987** · PHASE2 · COMPLETED · sponsor: **Nuon Therapeutics, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **DRUG:** Tranilast
- **DRUG:** Allopurinol
- **DRUG:** Combination - Tranilast and Allopurinol
- **DRUG:** 400 mg Allopurinol
- **DRUG:** High dose combination

## Key facts

- **NCT ID:** NCT01052987
- **Lead sponsor:** Nuon Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-11
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052987, "Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01052987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*